Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Summary

Insilico Medicine announced a strategic collaboration with Takeda to leverage its Pharma.AI platform for novel drug discovery across Takeda's therapeutic areas. The partnership combines Insilico's generative AI capabilities with Takeda's pharmaceutical expertise to advance drug candidates.